In my understanding human cells have may different types of RNA, which one are you sequencing?

We are measuring circular RNAs.

I'm curious why you are going through doctors and not direct to consumers at the begging? I understand FDA might force you to limit your marketing claims, however you now need to convince both physicians and consumers of the benefits of these tests. No? Where as I would imagine there will be enough early-adopters in the consumer space who'd be happy to pay for a test like this.

You can later move to the physicians space and assuringly get insurance companies cover the costs, when you have been more stablished.

Would love to learn more about your thinking and strategy here.

We believe that our RNA test can become a routine part of a doctor's visit, both as an early indicator of disease and — if there is disease — as a means to monitor the effectiveness of treatment.

Will your tests be available direct-to-consumer, or will patients have to go through health provider gatekeeping?

FTFY :)